VBID® Value-Based Insurance Design® Newsletter
June 2022 | VBID® Value-Based Insurance Design®
March 2022 | VBID® Value-Based Insurance Design®
June 2018
February 2018
Advertisement
Advertisement
Trending on AJMC
1
Merck, Moderna Cancer Vaccine Cuts Melanoma Recurrence Risk by 42%
2
Nephrologists Weigh Wins, Losses From 5 Years of Value-Based Kidney Care
3
Povetacicept Cuts Proteinuria by 52% in IgA Nephropathy at Week 36
4
FSGS Treatment and Low IgAN Drug Uptake: Jai Radhakrishnan, MD, MS
5